FI57260C - Foerfarande foer framstaellning av terapeutiskt verksamma 2-amino-3,4-dihydro-5-metyl-imidazo-/5,1-f/-as-triaziner - Google Patents
Foerfarande foer framstaellning av terapeutiskt verksamma 2-amino-3,4-dihydro-5-metyl-imidazo-/5,1-f/-as-triaziner Download PDFInfo
- Publication number
- FI57260C FI57260C FI3900/73A FI390073A FI57260C FI 57260 C FI57260 C FI 57260C FI 3900/73 A FI3900/73 A FI 3900/73A FI 390073 A FI390073 A FI 390073A FI 57260 C FI57260 C FI 57260C
- Authority
- FI
- Finland
- Prior art keywords
- group
- carbon atoms
- dihydro
- amino
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI793137A FI793137A (fi) | 1973-01-04 | 1979-10-10 | Foerfarande foer framstaellning av terapeutiskt verksamma 2-amino-3-hydro-imidazotriaziner |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB55373 | 1973-01-04 | ||
GB55373*[A GB1457873A (en) | 1973-01-04 | 1973-01-04 | Imidazotriazines |
Publications (2)
Publication Number | Publication Date |
---|---|
FI57260B FI57260B (fi) | 1980-03-31 |
FI57260C true FI57260C (fi) | 1980-07-10 |
Family
ID=9706420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI3900/73A FI57260C (fi) | 1973-01-04 | 1973-12-18 | Foerfarande foer framstaellning av terapeutiskt verksamma 2-amino-3,4-dihydro-5-metyl-imidazo-/5,1-f/-as-triaziner |
Country Status (19)
Country | Link |
---|---|
US (1) | US3941785A (de) |
JP (1) | JPS4995994A (de) |
AT (1) | AT336029B (de) |
AU (1) | AU474078B2 (de) |
BE (1) | BE809369A (de) |
CA (1) | CA1005057A (de) |
CH (1) | CH618170A5 (de) |
DE (1) | DE2364076A1 (de) |
ES (1) | ES422001A1 (de) |
FI (1) | FI57260C (de) |
FR (1) | FR2213058B1 (de) |
GB (1) | GB1457873A (de) |
IE (1) | IE38681B1 (de) |
IL (1) | IL43872A (de) |
LU (1) | LU69099A1 (de) |
NL (1) | NL7400095A (de) |
NO (1) | NO140301C (de) |
SE (1) | SE408179B (de) |
ZA (1) | ZA739534B (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK109578A (da) * | 1977-03-25 | 1978-09-26 | Allen & Hanburys Ltd | Fremgangsmaade til fremstilling af heterocycliske forbindelser |
US4096257A (en) * | 1977-05-23 | 1978-06-20 | American Cyanamid Company | Substituted imidazo [1,2-d]-as-triazines |
US4107309A (en) * | 1977-05-23 | 1978-08-15 | American Cyanamid Company | Substituted imidazo[1,2-d]-as-triazines |
US4126444A (en) * | 1977-11-22 | 1978-11-21 | American Cynamid Company | Substituted imidazo (1,5-D)-as-triazin-4-ols, and herbicidal use thereof |
US4308384A (en) * | 1978-09-18 | 1981-12-29 | Glaxo Group Limited | Production of triazinones |
DD244681A3 (de) * | 1985-12-02 | 1987-04-15 | Zeiss Jena Veb Carl | Vorrichtung zur positionierung von enden flexibler lichtleitelemente |
US6624181B1 (en) * | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
WO1999024433A1 (de) | 1997-11-12 | 1999-05-20 | Bayer Aktiengesellschaft | 2-phenyl-substituierte imidazotriazinone als phosphodiesterase inhibitoren |
DE19827640A1 (de) * | 1998-06-20 | 1999-12-23 | Bayer Ag | 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone |
TR200100500T2 (tr) | 1998-08-26 | 2001-06-21 | Smithkline Beecham Corporation | Pulmoner hastalıkların tedavisi için terapiler |
MXPA02001830A (es) * | 1999-08-21 | 2002-08-12 | Byk Gulden Lomberg Chem Fab | Combinacion sinergica de inhibidores de pde y agonista de beta 2 adrenoceptor. |
DE50209015D1 (de) * | 2001-05-09 | 2007-02-01 | Bayer Healthcare Ag | NEUE VERWENDUNG VON 2-Ä2-Ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenylÜ-5-methyl-7-propyl-3H-imidazoÄ5,1-fÜÄ1,2,4Ütriazin-4-on |
GB0113343D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel Heterocycles 2 |
GB0113344D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel heterocycles 3 |
DE10130167A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Imidazotriazine |
DE10135815A1 (de) | 2001-07-23 | 2003-02-06 | Bayer Ag | Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen |
DE10230605A1 (de) * | 2002-07-08 | 2004-01-29 | Bayer Ag | Substituierte Imidazotriazine |
DE10230604A1 (de) * | 2002-07-08 | 2004-01-29 | Bayer Ag | Heterocyclisch substituierte Imidazotriazine |
DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
US7462614B2 (en) * | 2003-04-01 | 2008-12-09 | Smithkline Beecham Corporation | Imidazotriazine compounds |
DE102005001989A1 (de) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenöse Formulierungen von PDE-Inhibitoren |
DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
EP2275095A3 (de) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenese durch modulation des Muscarinrezeptors |
EP2258358A3 (de) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenese mit Acetylcholinesterasehemmer |
AU2006299232A1 (en) * | 2005-09-29 | 2007-04-12 | Bayer Schering Pharma Aktiengesellschaft | PDE inhibitors and combinations thereof for the treatment of urological disorders |
CA2625153A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
JP2009513672A (ja) | 2005-10-31 | 2009-04-02 | ブレインセルス,インコーポレイティド | 神経発生のgaba受容体媒介調節 |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
WO2007104035A1 (en) * | 2006-03-08 | 2007-09-13 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
EP2021000A2 (de) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenese mittels angiotensin-modulation |
CA2651862A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
AU2007292848A1 (en) * | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20080103165A1 (en) * | 2006-09-19 | 2008-05-01 | Braincells, Inc. | Ppar mediated modulation of neurogenesis |
JP2010532319A (ja) * | 2007-06-13 | 2010-10-07 | バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト | 聴覚障害の処置用のpde阻害剤 |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE791025A (fr) * | 1971-11-19 | 1973-05-07 | Allen & Hanburys Ltd | Composes heterocycliques |
-
1973
- 1973-01-04 GB GB55373*[A patent/GB1457873A/en not_active Expired
- 1973-12-18 FI FI3900/73A patent/FI57260C/fi active
- 1973-12-18 NO NO4843/73A patent/NO140301C/no unknown
- 1973-12-18 ZA ZA739534A patent/ZA739534B/xx unknown
- 1973-12-19 AU AU63774/73A patent/AU474078B2/en not_active Expired
- 1973-12-20 IL IL43872A patent/IL43872A/xx unknown
- 1973-12-21 DE DE2364076A patent/DE2364076A1/de not_active Withdrawn
- 1973-12-26 US US05/427,558 patent/US3941785A/en not_active Expired - Lifetime
- 1973-12-28 CA CA189,199A patent/CA1005057A/en not_active Expired
- 1973-12-28 FR FR7346979A patent/FR2213058B1/fr not_active Expired
- 1973-12-31 IE IE2345/73A patent/IE38681B1/xx unknown
- 1973-12-31 JP JP49004782A patent/JPS4995994A/ja active Pending
-
1974
- 1974-01-02 CH CH9274A patent/CH618170A5/de not_active IP Right Cessation
- 1974-01-02 LU LU69099A patent/LU69099A1/xx unknown
- 1974-01-02 AT AT2374A patent/AT336029B/de not_active IP Right Cessation
- 1974-01-03 ES ES422001A patent/ES422001A1/es not_active Expired
- 1974-01-03 SE SE7400062A patent/SE408179B/xx unknown
- 1974-01-03 BE BE139496A patent/BE809369A/xx unknown
- 1974-01-04 NL NL7400095A patent/NL7400095A/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU6377473A (en) | 1975-06-19 |
CH618170A5 (de) | 1980-07-15 |
FR2213058A1 (de) | 1974-08-02 |
NO140301B (no) | 1979-04-30 |
US3941785A (en) | 1976-03-02 |
IL43872A0 (en) | 1974-03-14 |
FI57260B (fi) | 1980-03-31 |
AU474078B2 (en) | 1976-07-15 |
AT336029B (de) | 1977-04-12 |
ES422001A1 (es) | 1976-08-01 |
FR2213058B1 (de) | 1977-07-01 |
ATA2374A (de) | 1976-08-15 |
JPS4995994A (de) | 1974-09-11 |
BE809369A (fr) | 1974-07-03 |
CA1005057A (en) | 1977-02-08 |
IE38681B1 (en) | 1978-05-10 |
NL7400095A (de) | 1974-07-08 |
IE38681L (en) | 1974-07-04 |
SE408179B (sv) | 1979-05-21 |
IL43872A (en) | 1979-01-31 |
LU69099A1 (de) | 1974-04-02 |
ZA739534B (en) | 1974-11-27 |
NO140301C (no) | 1979-08-08 |
DE2364076A1 (de) | 1974-07-18 |
GB1457873A (en) | 1976-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI57260C (fi) | Foerfarande foer framstaellning av terapeutiskt verksamma 2-amino-3,4-dihydro-5-metyl-imidazo-/5,1-f/-as-triaziner | |
US3812127A (en) | 4-(quinolin-4-yl)piperazine-1-carboxylic acid esters | |
FI78097B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara (2-oxo-1,2,3,5-tatrahydroimidazo/2,1-b/ kinazolinyl)oxialkylamider. | |
Daly et al. | Analogs of caffeine and theophylline: Effect of structural alterations on affinity at adenosine receptors | |
US3702849A (en) | 4-(isoquinolin-1-yl) piperazine-1-carboxylic acid esters | |
US4289776A (en) | Xanthine derivatives | |
US5866580A (en) | Quinazoline derivatives and methods of using the same | |
CZ342595A3 (en) | Purine derivatives, process of their preparation and pharmaceutical compositions containing thereof | |
US3950343A (en) | Pyrroloisoquinoline derivatives | |
PL212407B1 (pl) | Zwiazek pochodny 8-chinolinoksantyny i 8-izochinolinoksantyny, jego zastosowanie, kompozycja farmaceutyczna zawierajaca zwiazek oraz sposób wytwarzania zwiazku | |
US4783530A (en) | 8-arylxanthines | |
NO134212B (de) | ||
US4276295A (en) | 3-Aromatic moiety substituted-4(3H)-quinazolinones, process for production thereof, and use thereof | |
Sakai et al. | Effects of alkyl substitutions of xanthine skeleton on bronchodilation | |
Novinson et al. | Adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors. 2. 3-Substituted 5, 7-dialkylpyrazolo [1, 5-a] pyrimidines | |
US4822800A (en) | Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties | |
US5314890A (en) | 1-7 disubstituted xanthine derivatives having antiasthmatic activity, their physiologically acceptable salts, pharmaceutical compositions containing them and process for their preparation | |
US5342841A (en) | Xanthine derivatives | |
US4801590A (en) | Pyrido(1,8)naphthyridinones, and their use as pharmaceuticals | |
Sinha et al. | Synthesis and antitumor properties of bis (quinaldine) derivatives | |
US5278186A (en) | Chromene derivatives, their production and use | |
US5378844A (en) | 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives, preparation process and antidepressant, nootropic and psychostimulant composition thereoff | |
US4176183A (en) | Novel naphthyridines | |
DD236523A5 (de) | Verfahren zur herstellung von chinolon- und naphtyridoncarbonsaeuren | |
US4372956A (en) | 5, 10-Dihydroimidazo[2,1-b]quinazolines and pharmaceutical compositions containing them |